Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23


Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART.

Vera JH, Bracchi M, Alagaratnam J, Lwanga J, Fox J, Winston A, Boffito M, Nelson M.

Brain Sci. 2019 Aug 9;9(8). pii: E195. doi: 10.3390/brainsci9080195.


Risk factors and impact of patterns of co-occurring comorbidities in people living with HIV.

De Francesco D, Underwood J, Bagkeris E, Anderson J, Williams I, Vera JH, Post FA, Boffito M, Johnson M, Mallon PWG, Winston A, Sabin CA; Pharmacokinetic and Clinical Observations in PeoPle Over fiftY (POPPY) study.

AIDS. 2019 Oct 1;33(12):1871-1880. doi: 10.1097/QAD.0000000000002293.


Acceptability and feasibility of using digital vending machines to deliver HIV self-tests to men who have sex with men.

Vera JH, Soni S, Pollard A, Llewellyn C, Peralta C, Rodriguez L, Dean G.

Sex Transm Infect. 2019 May 17. pii: sextrans-2018-053857. doi: 10.1136/sextrans-2018-053857. [Epub ahead of print]


Impact of musculoskeletal symptoms on physical functioning and quality of life among treated people with HIV in high and low resource settings: A case study of the UK and Zambia.

Van de Ven NS, Ngalamika O, Martin K, Davies KA, Vera JH.

PLoS One. 2019 May 13;14(5):e0216787. doi: 10.1371/journal.pone.0216787. eCollection 2019.


Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individuals.

De Francesco D, Winston A, Underwood J, Cresswell FV, Anderson J, Post FA, Williams I, Mallon PW, Sachikonye M, Babalis D, Vera JH, Bagkeris E, Milinkovic A, Sabin CA.

Int J STD AIDS. 2019 Apr;30(5):440-446. doi: 10.1177/0956462418817612. Epub 2019 Jan 10.


Assessment and Management of HIV-Associated Cognitive Impairment: Experience from a Multidisciplinary Memory Service for People Living with HIV.

Alford K, Banerjee S, Nixon E, O'Brien C, Pounds O, Butler A, Elphick C, Henshaw P, Anderson S, Vera JH.

Brain Sci. 2019 Feb 8;9(2). pii: E37. doi: 10.3390/brainsci9020037.


Physical activity and quality of life in people living with HIV.

Martin K, Naclerio F, Karsten B, Vera JH.

AIDS Care. 2019 May;31(5):589-598. doi: 10.1080/09540121.2019.1576848. Epub 2019 Feb 2.


Increased Dolutegravir Peak Concentrations in People Living With Human Immunodeficiency Virus Aged 60 and Over, and Analysis of Sleep Quality and Cognition.

Elliot ER, Wang X, Singh S, Simmons B, Vera JH, Miller RF, Fitzpatrick C, Moyle G, McClure M, Boffito M.

Clin Infect Dis. 2019 Jan 1;68(1):87-95. doi: 10.1093/cid/ciy426.


Neurosyphilis in patients with HIV.

Hobbs E, Vera JH, Marks M, Barritt AW, Ridha BH, Lawrence D.

Pract Neurol. 2018 Jun;18(3):211-218. doi: 10.1136/practneurol-2017-001754. Epub 2018 Feb 24. Review.


Global sexual health education: STIF in Zambia.

Vera JH, Ngalamika O, Fox A, Collins E, Grundy-Bowers M.

Sex Transm Infect. 2018 Feb;94(1):2. doi: 10.1136/sextrans-2017-053448. No abstract available.


PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.

Vera JH, Ridha B, Gilleece Y, Amlani A, Thorburn P, Dizdarevic S.

Eur J Nucl Med Mol Imaging. 2017 May;44(5):895-902. doi: 10.1007/s00259-016-3602-3. Epub 2017 Jan 5. Review.


Defining cognitive impairment in people-living-with-HIV: the POPPY study.

De Francesco D, Underwood J, Post FA, Vera JH, Williams I, Boffito M, Sachikonye M, Anderson J, Mallon PW, Winston A, Sabin CA; POPPY study group.

BMC Infect Dis. 2016 Oct 28;16(1):617.


Nanoflow-Nanospray Mass Spectrometry Metabolomics Reveals Disruption of the Urinary Metabolite Profiles of HIV-Positive Patients on Combination Antiretroviral Therapy.

Chetwynd AJ, Samarawickrama A, Vera JH, Bremner SA, Abdul-Sada A, Gilleece Y, Holt SG, Hill EM.

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):e45-e53. doi: 10.1097/QAI.0000000000001159.


Highlights from the Conference on Retroviruses and Opportunistic Infections 2016: 22-25 February 2016, Boston, Massachusetts, USA.

Fidler S, Ananworanich J, Vandekerckhove L, Kiselinova M, Schuetz A, Vera JH, Dwyer E, Alagaratnam J.

J Virus Erad. 2016 Apr 1;2(2):124-30. No abstract available.


Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.

Vera JH, Guo Q, Cole JH, Boasso A, Greathead L, Kelleher P, Rabiner EA, Kalk N, Bishop C, Gunn RN, Matthews PM, Winston A.

Neurology. 2016 Apr 12;86(15):1425-1432. doi: 10.1212/WNL.0000000000002485. Epub 2016 Feb 24.


Atherosclerosis is Evident in Treated HIV-Infected Subjects With Low Cardiovascular Risk by Carotid Cardiovascular Magnetic Resonance.

Rose KA, Vera JH, Drivas P, Banya W, Keenan N, Pennell DJ, Winston A.

J Acquir Immune Defic Syndr. 2016 Apr 15;71(5):514-21. doi: 10.1097/QAI.0000000000000900.


The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age.

Vera JH, Jackson A, Dickinson L, Else L, Barber T, Mora-Peris B, Back D, Boffito M, Winston A.

HIV Clin Trials. 2015 Jan-Feb;16(1):39-42. doi: 10.1179/1528433614Z.0000000006. Epub 2015 Jan 14.


Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy.

Mora-Peris B, Watson V, Vera JH, Weston R, Waldman AD, Kaye S, Khoo S, Mackie NE, Back D, Winston A.

J Antimicrob Chemother. 2014 Jun;69(6):1642-7. doi: 10.1093/jac/dku018. Epub 2014 Feb 11.


Can antiretroviral therapy prevent HIV-associated cognitive disorders?

Winston A, Vera JH.

Curr Opin HIV AIDS. 2014 Jan;9(1):11-6. doi: 10.1097/COH.0000000000000016. Review.


Pharmacokinetic profile and safety of 150 mg of maraviroc dosed with 800/100 mg of darunavir/ritonavir all once daily, with and without nucleoside analogues, in HIV-infected subjects.

Mora-Peris B, Croucher A, Else LJ, Vera JH, Khoo S, Scullard G, Back D, Winston A.

J Antimicrob Chemother. 2013 Jun;68(6):1348-53. doi: 10.1093/jac/dkt006. Epub 2013 Jan 30.


Supplemental Content

Loading ...
Support Center